Metropolitan Life Insurance Company (MetLife)’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,029
Closed -$56.8K 1723
2024
Q1
$56.8K Hold
3,029
﹤0.01% 1340
2023
Q4
$65.6K Hold
3,029
﹤0.01% 1303
2023
Q3
$62.3K Buy
3,029
+138
+5% +$2.84K ﹤0.01% 1275
2023
Q2
$136K Hold
2,891
0.01% 871
2023
Q1
$121K Sell
2,891
-257
-8% -$10.8K 0.01% 908
2022
Q4
$120K Hold
3,148
0.01% 961
2022
Q3
$123K Hold
3,148
0.01% 898
2022
Q2
$102K Buy
+3,148
New +$102K ﹤0.01% 1043
2022
Q1
Sell
-1,024
Closed -$43.6K 2614
2021
Q4
$43.6K Buy
1,024
+3
+0.3% +$128 ﹤0.01% 2711
2021
Q3
$45.2K Sell
1,021
-41
-4% -$1.82K ﹤0.01% 2773
2021
Q2
$60.3K Sell
1,062
-172
-14% -$9.77K ﹤0.01% 2658
2021
Q1
$92.4K Buy
1,234
+25
+2% +$1.87K ﹤0.01% 2449
2020
Q4
$105K Sell
1,209
-35
-3% -$3.03K ﹤0.01% 2341
2020
Q3
$76K Sell
1,244
-20
-2% -$1.22K ﹤0.01% 2366
2020
Q2
$52.6K Sell
1,264
-2,318
-65% -$96.4K ﹤0.01% 2491
2020
Q1
$103K Sell
3,582
-113
-3% -$3.25K ﹤0.01% 2010
2019
Q4
$267K Sell
3,695
-20
-0.5% -$1.44K ﹤0.01% 1718
2019
Q3
$521K Buy
3,715
+128
+4% +$18K 0.01% 1264
2019
Q2
$657K Sell
3,587
-83
-2% -$15.2K 0.01% 1131
2019
Q1
$584K Buy
3,670
+174
+5% +$27.7K 0.01% 1196
2018
Q4
$335K Sell
3,496
-12
-0.3% -$1.15K 0.01% 1483
2018
Q3
$496K Sell
3,508
-69
-2% -$9.75K 0.01% 1357
2018
Q2
$560K Sell
3,577
-9,489
-73% -$1.49M 0.01% 1238
2018
Q1
$2.1M Buy
13,066
+1,314
+11% +$212K 0.03% 505
2017
Q4
$1.94M Sell
11,752
-11,700
-50% -$1.93M 0.03% 567
2017
Q3
$1.46M Hold
23,452
0.01% 1055
2017
Q2
$1.87M Buy
23,452
+2,112
+10% +$168K 0.01% 971
2017
Q1
$1.52M Hold
21,340
0.01% 1059
2016
Q4
$1.09M Buy
21,340
+1,618
+8% +$82.6K 0.01% 1252
2016
Q3
$908K Hold
19,722
0.01% 1340
2016
Q2
$594K Buy
19,722
+7,645
+63% +$230K ﹤0.01% 1576
2016
Q1
$387K Buy
12,077
+2,335
+24% +$74.8K ﹤0.01% 1745
2015
Q4
$568K Hold
9,742
﹤0.01% 1538
2015
Q3
$412K Hold
9,742
﹤0.01% 1768
2015
Q2
$711K Buy
+9,742
New +$711K 0.01% 1515
2015
Q1
Sell
-4,668
Closed -$171K 2406
2014
Q4
$171K Sell
4,668
-3,609
-44% -$132K ﹤0.01% 2515
2014
Q3
$261K Buy
+8,277
New +$261K ﹤0.01% 2186